Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies
- 1 March 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 315 (4) , 942-949
- https://doi.org/10.1016/j.bbrc.2004.01.156
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Allosteric Modulation of Human P-glycoproteinPublished by Elsevier ,2003
- Mammalian ABC Transporters in Health and DiseaseAnnual Review of Biochemistry, 2002
- BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTERAnnual Review of Pharmacology and Toxicology, 1999
- Stimulation of P‐glycoprotein‐mediated drug transport by prazosin and progesteroneEuropean Journal of Biochemistry, 1999
- Availability of PSC833, a substrate and inhibitor of P-glycoproteins, in various concentrations of serumJNCI Journal of the National Cancer Institute, 1998
- How does P-glycoprotein recognize its substrates?Seminars in Cancer Biology, 1997
- GENETIC ANALYSIS OF THE MULTIDRUG TRANSPORTERAnnual Review of Genetics, 1995
- Allosteric regulation of [3H]vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipineBiochemical Pharmacology, 1995
- The multidrug‐resistance‐reverser verapamil interferes with cellular P‐glycoprotein‐mediated pumping of daunorubicin as a non‐competing substrateEuropean Journal of Biochemistry, 1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993